Kaushal Mohit
SEC insider (Form 3/4/5 filer). CIK 0001683021. Director at Oncology Institute, Inc. (TOI). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in CERRITOS, CA.
Companies Kaushal Mohit has filed insider reports for
- Oncology Institute, Inc. (TOI): Director
Kaushal Mohit
CIK: 0001683021
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TOI
Oncology Institute, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 27, 2026TOI
Oncology Institute, Inc.
AwardDirect33.1K shares- - Apr 16, 2026TOI
Oncology Institute, Inc.
SaleDirect38.4K shares at avg. $3.50$135K - Apr 14, 2026TOI
Oncology Institute, Inc.
SaleDirect57.3K shares at avg. $3.50$201K - Nov 20, 2025TOI
Oncology Institute, Inc.
AwardDirect50.9K shares- - Nov 20, 2025TOI
Oncology Institute, Inc.
AwardDirect40.1K shares- - Nov 22, 2024TOI
Oncology Institute, Inc.
AwardDirect56K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 | TOI Oncology Institute, Inc. | Award | 33,133 | - | $0 | Direct |
| Apr 16, 2026 | TOI Oncology Institute, Inc. | Sale | 38,433 | $3.50 | $134,535 | Direct |
| Apr 14, 2026 | TOI Oncology Institute, Inc. | Sale | 57,286 | $3.50 | $200,598 | Direct |
| Nov 20, 2025 | TOI Oncology Institute, Inc. | Award | 50,926 | - | - | Direct |
| Nov 20, 2025 | TOI Oncology Institute, Inc. | Award | 40,123 | - | - | Direct |
| Nov 22, 2024 | TOI Oncology Institute, Inc. | Award | 56,000 | - | $0 | Direct |
1-6 of 6 transactions